Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Poziotinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Spectrum to lay off R&D staff after FDA drug rejection
    Spectrum to lay off R&D staff after FDA drug rejection

    29 Nov 2022

    // BIOPHARMADIVE

    https://www.biopharmadive.com/news/spectrum-fda-rejection-poziotinib-layoffs/637358/#:~:text=Spectrum%20Pharmaceuticals%20will%20lay%20off,immediately%E2%80%9D%20discontinue%20investment%20into%20poziotinib.

    BIOPHARMADIVE
    29 Nov 2022
    Share Share
    Spectrum implodes after aharsh public slapdown and a CRL from Richard Pazdur
    Spectrum implodes after aharsh public slapdown and a CRL from Richard Pazdur

    28 Nov 2022

    // ENDPTS

    https://endpts.com/spectrum-implodes-after-a-harsh-public-slapdown-and-now-a-crl-from-richard-pazdur/

    ENDPTS
    28 Nov 2022
    Share Share
    FDA hands Hanmi’s partner, Spectrum, a poziotinib CRL for supplementary data
    FDA hands Hanmi’s partner, Spectrum, a poziotinib CRL for supplementary data

    25 Nov 2022

    // KOREABIOMED

    http://www.koreabiomed.com/news/articleView.html?idxno=15138

    KOREABIOMED
    25 Nov 2022
    Share Share
    Spectrum Provides Update on Poziotinib Following FDA Oncologic Advisory Meeting
    Spectrum Provides Update on Poziotinib Following FDA Oncologic Advisory Meeting

    22 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220922005870/en

    BUSINESSWIRE
    22 Sep 2022
    Share Share
    FDA staff flag concerns with cancer treatments from Spectrum, Oncopeptides
    FDA staff flag concerns with cancer treatments from Spectrum, Oncopeptides

    21 Sep 2022

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-staff-raises-concerns-spectrum-pharmas-cancer-drug-2022-09-20/

    REUTERS
    21 Sep 2022
    Share Share
    Spectrum Announces Data from Presentation for Poziotinib in NSCLC Patients
    Spectrum Announces Data from Presentation for Poziotinib in NSCLC Patients

    10 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220910005015/en

    BUSINESSWIRE
    10 Sep 2022
    Share Share